Early Response Assessment to Targeted Therapy Using 3′-deoxy-3′[(18)F]-Fluorothymidine (<sup>18</sup>F-FLT) PET/CT in Lung Cancer

Early Response Assessment to Targeted Therapy Using 3′-deoxy-3′[(18)F]-Fluorothymidine (<sup>18</sup>F-FLT) PET/CT in Lung Cancer

Although 2-deoxy-2-[18F]-fluoro-D-glucose positron emission tomography/computed tomography (<sup>18</sup>F-FDG PET/CT) is a sensitive nuclear medicine modality, specificity for characterizing lung cancer is limited. Tumor proliferation and early response to molecularly targeted therapy c...

Full description

Bibliographic Details
Main Authors: Kalevi Kairemo, Elmer B. Santos, Homer A. Macapinlac, Vivek Subbiah
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Diagnostics
Subjects:
<sup>18</sup>f-flt
<sup>18</sup>f-flt pet/ct
lung cancer
response to therapy
small cell lung cancer
non-small cell lung cancer
Online Access:https://www.mdpi.com/2075-4418/10/1/26

Similar Items

Similar Items